Option Care Health Reports Strong Q2 Results with Revenue Growth and Adjusted EBITDA Increase
Option Care Health (NASDAQ:OPCH) reported second-quarter results that exceeded internal expectations, driven by a 7% sequential revenue increase to $1.4 billion and an adjusted EBITDA rise of 12% to $117.5 million. The company also generated strong operating cash flow of $184 million during the quarter. Acute therapies showed high-single-digit organic growth for two consecutive quarters, while chronic revenue improved sequentially as its CID portfolio began stabilizing after a first-quarter reset. However, management noted that CID-related challenges are still expected to reduce 2026 revenue by approximately 600 basis points and gross profit by $55 million. The company maintained full-year revenue guidance at $5.675 billion-$5.775 billion while narrowing adjusted EBITDA guidance to $480 million-$495 million and adjusted EPS guidance to $1.85-$1.92. Additionally, Option Care Health repurchased $150 million of shares during the quarter.
Tickers: $OPCH
Topics: adjusted_ebitda adjusted_eps cash_flow guidance_update revenue